Indoco Remedies gets warning letter for Goa facility

17 Dec 2024 Evaluate

Indoco Remedies has received a warning letter from the US Food and Drug Administration (USFDA) for Plant II & Plant III facility located at Verna Industrial Estate Area, Verna, Goa, India (Facility) on December 17, 2024. This facility was inspected from July 16, 2024 to July 26, 2024. The Company remains committed to work closely with the USFDA and continues to enhance its compliance on an ongoing basis.

Earlier, the company had received Official Action Indicated (OAI) status from the USFDA for said facility. 

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

247.90 -8.25 (-3.22%)
04-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1709.40
Dr. Reddys Lab 1109.75
Cipla 1415.55
Lupin 1971.10
Zydus Lifesciences 866.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...